Global Plastic Surgery Devices Market is expected to grow with the CAGR of 10.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-plastic-surgery-devices-market
Global plastic surgery devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global plastic surgery devices market are introducing strong range of plastic surgery devices’ products provider along with launching new plastic surgery devices’ products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.
For instance:
- In October 2017, Merz Pharma GmbH & Co KGaA has announced the partnership with Teijin. The primary purpose of this partnership is to Bring Xeomin (incobotulinumtoxinA) to Japan market. This partnership has helped to enhance geographical presence of the company.
Allergan (A Subsidiary of AbbVie Inc.), is the dominating player in global plastic surgery devices market. The other key players existing in the market are Bohus BioTech AB, ADODERM GmbH, Bioha Laboratories, Surgisil LLP, Solta Medical (A Subsidiary of Bausch Health Companies Inc.), B. Braun Melsungen AG, Innovia Medical, Galderma, Merz Pharma, Coloplast Corp, Johnson & Johnson Services, Inc., AirXpanders, Inc., BonashMedical, CEREPLAS, DPS Technology Development Ltd., Establishment Labs S.A., Implantech, KOKEN CO., LTD. LABORATOIRES ARION, PMT Corporation, POLYTECH Health & Aesthetics GmbH, Sebbin, Shanghai Kangning Medical Supplies Ltd., Sientra, Inc., Wanhe, Xilloc Medical B.V., Integra LifeSciences, an KARL STORZ SE & Co. KG among others.
Allergan (A Subsidiary of AbbVie Inc.)
Allergan (A Subsidiary of AbbVie Inc.) headquartered in Dublin, Ireland. Company is focusing on research and development, exclusively in central nervous system, gastroenterology, and medical-aesthetic therapeutic area. The company has wide product categories such as Central Nervous System, Eye Care, Gastroenterology, Medical-Aesthetic in which Medical-Aesthetic is the market focused category.
For instance,
- In October 2020, Allergan (A Subsidiary of AbbVie Inc.) has announced that it has agreed with Luminera, which is a privately held, aesthetics company with a portfolio and pipeline of dermal filler products. It is estimated that this acquisition anticipated strengthening footprints in the Israel market.
The company has wide presence across Asia Pacific, Europe, Middle East and Africa, North America.
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. headquartered in New Jersey, U.S. Johnson & Johnson Services, Inc is founded in the year 1886. The company is focused on personal healthcare used in the beauty, over-the-counter pharmaceutical, baby care, oral care, women’s health, pharmaceutical, medical devices and wound care markets. The company has various product categories that are consumer health products, pharmaceutical products and medical devices in which medical devices is the market focused category.
For instance,
- In September 2020, Johnson & Johnson Services, Inc. announced the launch of the Skincare of the Future QuickFire Challenge in collaboration with Zhejiang Tmall Technology Co., Ltd. This strategy is calling for new innovative product, service and technology innovations to help consumers tackle some of the world's toughest skincare challenges.
The company has presence in Americas, Europe, and Asia-Pacific. The company also has various subsidiary companies such as Acclarent, Inc. (Delaware), Actelion Pharmaceuticals US, Inc. (Delaware), Albany Street LLC (New Jersey), ALZA Corporation (Delaware), Alza Land Management, Inc. (Delaware) and others.
Galderma
Galderma headquartered in Switzerland, Europe. Galderma founded in the year 1981. The company is focusing on broad range of skin health needs. Moreover, company offer a range of leading medical and consumer skin health brands. The company has product categories which are for Acne, Aesthetics, Consumer Care, Onychomycosis, Prescription, Rosacea, Skin Cancer, Skin Care in which for Aesthetics is the market focused categories.
For instance,
- In November 2020, Galderma launched Dysport in China for treatment of glabellar lines. It is predicted that, this product launch anticipated enhance the business growth as well as strengthen the footprints in China market.
The company has presence across Europe, North America, and Asia-Pacific.
